The Cell & Viral Immunotherapy Series is dedicated to accelerating the progression of the next generations of safe, effective and commercially successful cell and viral immunotherapies.
Our targeted events bring together scientific and business leaders from large pharma, biotech & academia to overcome discovery, development and commercialization challenges affecting the delivery of these novel therapies to patients in need.
“A nice blend of academic, biotech, and pharmaceutical attendance in an environment that encourages cross-fertilization of ideas within cell therapy.”
C4 Therapeutics
